59
Growth Score
pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1175389
Pulmonem develops treatments for COVID-19 inflammation, focusing on clinical trials and regulatory approvals.
About the Company
Pulmonem focuses on biotechnology, specifically developing treatments to combat inflammation caused by COVID-19. The company is engaged in clinical trials to demonstrate the efficacy of a generic drug in arresting the development of COVID-19 related inflammation. Pulmonem collaborates with research institutions like the McGill University Health
Centre to advance its clinical trials and has received approvals from regulatory bodies such as the FDA and Health Canada.
